Related Experiment Video
Updated: Jul 30, 2025
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.1K
Prostaglandin analogs in ophthalmology
S Subbulakshmi1, Srinivasan Kavitha, Rengaraj Venkatesh
1Department of Glaucoma, Aravind Eye Hospital, Puducherry, India.
Indian Journal of Ophthalmology
|May 19, 2023
Summary
Glaucoma treatment now prioritizes prostaglandin analogs (PGAs) over beta-blockers due to superior efficacy and safety. This review covers current PGAs and emerging options for managing intraocular pressure (IOP).
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma is a leading cause of irreversible blindness globally.
- Elevated intraocular pressure (IOP) is a primary risk factor for optic nerve damage in glaucoma.
- Pharmacotherapy is the cornerstone of glaucoma management.
Purpose of the Study:
- To review current prostaglandin analogs (PGAs) used in glaucoma treatment.
- To discuss the advantages of PGAs over traditional therapies like beta-blockers.
- To highlight newer, promising drugs for glaucoma management.
Main Methods:
- Literature review of clinical studies and pharmacological data.
- Analysis of treatment guidelines and drug efficacy.
- Comparative assessment of different glaucoma medications.
Main Results:
- Prostaglandin analogs (PGAs) are now first-line therapy for glaucoma.
- PGAs offer superior IOP control, once-daily dosing, and better systemic safety.
- A shift from beta-blockers to PGAs has been observed in clinical practice.
Conclusions:
- PGAs represent a significant advancement in glaucoma pharmacotherapy.
- Current and emerging PGAs provide effective options for IOP reduction.
- Continued research into novel glaucoma treatments is essential.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
226
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
226
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
523
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
523
01:27Open Angle Glaucoma: Treatment
498
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
498
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
800
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
800
01:28Angle Closure Glaucoma: Treatment
584
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
584
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K